ARCHIVES

TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997

ASCO Explores White, Minority Cancer Problem

July 13, 1990

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982